Drug Profile
Research programme: melanin-concentrating hormone receptor 1 antagonists - Lundbeck
Alternative Names: SNAP 102739; SNAP 7941; SNAP 94847Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Lundbeck Research USA
- Class Anilides; Piperidines; Pyridones
- Mechanism of Action MCHR1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders; Major depressive disorder
- Discontinued Obesity
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Anxiety-disorders in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Major depressive disorder in USA
- 19 Mar 2003 Synaptic Pharmaceutical has been acquired by Lundbeck A/S